241 related articles for article (PubMed ID: 4210713)
1. [Incidence of primary hyperuricemia in ambulant patients (author's transl)].
Babucke G; Mertz DP
MMW Munch Med Wochenschr; 1974 Apr; 116(17):875-80. PubMed ID: 4210713
[No Abstract] [Full Text] [Related]
2. [Gout in women].
Schilling A
Z Rheumaforsch; 1968 Jun; 27(5):192-8. PubMed ID: 5670263
[No Abstract] [Full Text] [Related]
3. [Alterations of lipid metabolism in primary gout and hyperuircemia].
Mertz DP; Zaar I; Klöpfer-Zaar M; Henninges D; Thieme G; Scheier CA
Dtsch Med Wochenschr; 1971 Mar; 96(12):488-93. PubMed ID: 5548321
[No Abstract] [Full Text] [Related]
4. [Changes between 1948 and 1970 in the epidemiology and clinical features of primary gout].
Babucke G; Mertz DP
Dtsch Med Wochenschr; 1973 Feb; 98(5):183-8. PubMed ID: 4684527
[No Abstract] [Full Text] [Related]
5. [Diabetes and hyperuricaemia (author's transl)].
Hasslacher C; Wahl P; Vollmar J
Dtsch Med Wochenschr; 1974 Dec; 99(49):2506-10. PubMed ID: 4434848
[No Abstract] [Full Text] [Related]
6. [Epidemiology and clinical aspect of primary gout. Observations between 1948 and 1968].
Mertz DP; Babucke G
Munch Med Wochenschr; 1971 Apr; 113(16):617-24. PubMed ID: 5313655
[No Abstract] [Full Text] [Related]
7. The epidemiology of hyperuricemia.
Healy LA; Hall AP
Bull Rheum Dis; 1970 Apr; 20(8):600-3. PubMed ID: 5472825
[No Abstract] [Full Text] [Related]
8. [Definition and treatment requirements of uricemia].
Mertz DP
Fortschr Med; 1977 Jan; 95(1):8-14. PubMed ID: 832829
[No Abstract] [Full Text] [Related]
9. [Dyslipoproteinaemia in primary gout].
Mertz DP; Babucke G
Dtsch Med Wochenschr; 1973 Aug; 98(31):1457-62. PubMed ID: 4718868
[No Abstract] [Full Text] [Related]
10. [Serum uric acid levels and the occurrence of hyperuricemia].
Thiele P; Tellkamp F; Feuerstein C; Heidelmann G
Z Arztl Fortbild (Jena); 1971 Jun; 65(12):595-600. PubMed ID: 5112870
[No Abstract] [Full Text] [Related]
11. [Investigations concerning the incidence of disorders of lipid and carbohydrate metabolism in primary gout and symptomless hyperuricaemia (author's transl)].
Frank O
Wien Klin Wochenschr; 1974 May; 86(9):252-6. PubMed ID: 4363464
[No Abstract] [Full Text] [Related]
12. [Urolithiasis in gout and hyperuricemic syndrome].
Vachtenheim J; Srámek F
Beitr Rheumatol; 1972; 18():56-60. PubMed ID: 4649119
[No Abstract] [Full Text] [Related]
13. [Metabolic disorders in hyperuricemia].
Turpin G
Rev Prat; 1983 Oct; 33(43):2271-80. PubMed ID: 6635505
[No Abstract] [Full Text] [Related]
14. [The present health situation of adults (author's transl)].
Mertz DP
Med Klin; 1977 Sep; 72(38):1519-24. PubMed ID: 904546
[No Abstract] [Full Text] [Related]
15. [Effect of decrease in hyperuricemia levels on joint, kidney and other symptoms in patients with gout].
Kawenoki-Minc E
Ter Arkh; 1987; 59(4):25-8. PubMed ID: 3589999
[No Abstract] [Full Text] [Related]
16. [Extraarticular diseases and findings in gout].
Heidelmann G; Thiele P; Schröder HE
Z Gesamte Inn Med; 1982 Jul; 37(13):410-6. PubMed ID: 7136080
[TBL] [Abstract][Full Text] [Related]
17. [Lipid disorders in gout and in hyperuricemia with myalgia].
Roux H; Vovan L; Dutertre P; Serratrice G; Recordier AM
Mars Med; 1972; 109(10):609-25. PubMed ID: 4659841
[No Abstract] [Full Text] [Related]
18. [Incidence of coronary disease and other metabolic diseases in 80 gout patients].
Pianzola EL; Ulloa Lugo S; Robles Gil J
Arch Inst Cardiol Mex; 1979; 49(1):25-33. PubMed ID: 434957
[TBL] [Abstract][Full Text] [Related]
19. [Frequency and distribution of types of hyperlipoproteinemia with life-shortening risk factors among ambulant patients (author's transl)].
Mertz DP; Hohneck A
Med Klin; 1975 Jul; 70(28-29):1209-13. PubMed ID: 170497
[TBL] [Abstract][Full Text] [Related]
20. [Various epidemiological aspects of hyperuricemia and gout in Mexico: incidence and the cardiovascular risk factor].
Robles Gil J; Armas C
Arch Inst Cardiol Mex; 1978; 48(6):1121-41. PubMed ID: 727844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
